Cellectricon

About:

Cellectricon is a leading provider of advanced cell-based screening services to accelerate drug discovery.

Website: http://www.cellectricon.com/

Twitter/X: Cellectricon

Top Investors: Investor Growth Capital Limited, Karolinska

Description:

Cellectricon is a leading provider of advanced cell-based screening services to accelerate drug discovery. Exploiting their Cellaxess® Elektra platform, their Discovery Services offering is ideal for compound profiling in excitable primary cells and native tissue. Their services help researchers identify phenotypic effects in highly relevant biological models early enough in a project’s lifecycle to add real value to the decision of whether to pursue or eliminate a compound, which translates to considerable cost savings in the drug development business. With their new services-based business model, we are well-enabled to respond to the demands and challenges faced by the drug discovery industry. Their dedicated team of expert neurobiologists and extensive pharmaceutical industry experience, position us well as a preferred partner Over the past year they have collaborated with several large Pharma partners.